MPS Powered by Eureka

Gene Editing Technologies

ISSN: 2950-564X (Print)
eISSN: 2950-5658 (Online)

Gene Editing Technologies publishes full-length/mini-reviews/reviews, original research, and guest-edited thematic issues in areas of gene editing.The journal aims to drive forward the science and application of gene editing in diverse areas of biology and medicine. Areas of interest cover, but are not limited to:

• Agricultural Biotechnology
• Base Editing
• Bioinformatics and Computational Tools
• Clinical Trials
• Comparative Studies of Gene Editing Technologies
• CRISPR-Cas Systems
• Emerging Gene Editing Technologies
• Gene Therapy
• Mechanisms of Gene Editing
• Prime Editing
• TALENs
• Zinc Finger Nucleases (ZFNs)

Start Submission

Generative AI for Retail Innovation

Start Submission

Generative AI in Modern Healthcare

Start Submission

Genes and Cancer Risk

Start Submission

Genes and Cancer Risk

Start Submission

Genetic Diversity of Coronaviruses: From SARS-CoV to SARS-CoV-2

Start Submission

Genetic Predisposition and Autism Spectrum Disorders: A Review of the Epigenetic Role of Vaccine Adjuvants and Environmental Pollutants

Start Submission

Genome Editing in Bacteria

Start Submission

Genome Size and Genetic Homogeneity of Regenerated Plants: Methods and Applications

Start Submission

Geriatric Anesthesia: A Practical Guide

Start Submission

Global Emerging Innovation Summit

Start Submission

Glucolipid Metabolic Disorders

ISSN: 2949-9011 (Print)
eISSN: 2949-902X (Online)

Glucolipid Metabolic Disorders is an international peer-reviewed, multi-disciplinary journal for physicians, clinicians, and scientists with interest in glucose and lipid metabolic disorders in pathological processes, as well as the therapeutics targeting these disorders to treat human diseases. Glucolipid Metabolic Disorders publishes original research articles, guidelines, reviews, and commentaries on a broad range of topics. Glucolipid Metabolic Disorders is most interested in manuscripts that address important advances in glucolipid metabolomics and the clinical application of targeting glucose and lipid metabolism. Areas of interest cover, but are not limited to: • Clinical applications of targeting glucose and lipid metabolism to improve patient care and outcomes • Clinical trials illustrating the use of targeting glucose and lipid metabolism • Conceptual and characterization of glucolipid metabolic disorders • Mechanisms of glucolipid metabolic disorders in diseases • Metabolomics on glucose and lipids • Methodologies & preclinical and clinical applications of glucolipid metabolomics • Novel techniques & approaches for the advancement of glucolipid metabolomics • Translational research in glucolipid metabolomics

Start Submission

Glycals and Their Derivatives

Start Submission

Glycosylation and Glycation in Health and Diseases

Start Submission

Graphene-based Carbocatalysis: Synthesis, Properties and Applications

Start Submission